This year, their research reached the Division level as select Grade 12 STEM students represented ASHS for the first time at ...

Black women, from Althea Gibson to Venus and Serena Williams, to Naomi Osaka and Coco Gauff, have dominated women’s tennis for decades. But their Black male counterparts have not had nearly as much ...

Jannik Sinner Calling Time on 2026 Means Alexander Zverev Should Finish the Year No. 1 Oh me, oh my, it’s actually happening: Alexander Zverev will finish 2026 as the No. 1 player in men's tennis.

Seven of the 10 companies participating in the fall cohorts of MassBio and SCbio’s Drive program are based in the United States, including four in Massachusetts. To propel breakthrough science while ...

BUFFALO, N.Y. – Ten early-stage life science and biotech companies will present their technologies during NewYorkBIO’s Buffalo Mini-Pitch Day at the University at Buffalo, hosted by UB Business and ...

2026 has definitely been Alexandra Eala‘s most successful season on the Tour so far. Not only did she capture her maiden WTA title at the Citi Open, but her popularity skyrocketed due to her form.

Former World No. 11 Sam Querrey delivered a bold take on rising star Alex Eala. Starting the year at No. 53, Eala has risen to No. 20 amid the 2026 Cincinnati Open. Speaking on the Tennis Channel Live ...

Each year, this special report spotlights women moving the needle across pharma, biotech, medtech, academia, venture capital and other pockets of the life sciences. (iStock / Getty Images Plus) ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. For 18 months, the Trump administration has been accused by science ...

The Nature Index's first social-sciences ranking shows the United States as the clear leader, with 9 out of the top 10 institutions. China's Tsinghua University is the only institution outside the ...

The life sciences tools and services sector is back in focus after Merck KGaA (MKGAF) agreed to acquire Bio-Techne (TECH) for $73 per share in cash, valuing the deal at an enterprise value of around ...

From Johnson & Johnson and Roche to Eli Lilly, Pfizer, Novartis, Merck & Co and AstraZeneca, these life sciences leaders are advancing healthcare systems Life sciences companies are playing an ...